Brief: Ovid Therapeutics Q2 EPS USD -0.08
13/08/2026 13:31
BRIEF-Ovid Therapeutics Q2 EPS USD -0.08 Aug 13 (Reuters) - Ovid Therapeutics Q2 net income USD -15.009 million.
- Q2 operating expenses USD 16.431 million
- Q2 revenue USD 733 thousand vs. IBES estimate USD 0
Recent news on Ovid Therapeutics
See all newsOvid Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Ovid Therapeutics Q2 revenue beats estimates
Brief: Ovid Therapeutics Q2 EPS USD -0.08
Ovid Therapeutics Inc. expected to post a loss of 11 cents a share - Earnings Preview
Brief: Ovid Therapeutics Appoints Leading Physician-Scientist And Biotech Innovator Anna Greka, M.D., Ph.D., To Board Of Directors